about
Antitumor effects of CD40 ligand-expressing endothelial progenitor cells derived from human induced pluripotent stem cells in a metastatic breast cancer model.Advanced new strategies for metastatic cancer treatment by therapeutic stem cells and oncolytic virotherapy.Emerging monoclonal antibodies and related agents for the treatment of chronic lymphocytic leukemia.Targeting of the tumor necrosis factor receptor superfamily for cancer immunotherapy.Engineering protein self-assembling in protein-based nanomedicines for drug delivery and gene therapy.CD40 ligand-expressing recombinant vaccinia virus promotes the generation of CD8(+) central memory T cells.Prospects for combined use of oncolytic viruses and CAR T-cells.CAR-T Cells and Oncolytic Viruses: Joining Forces to Overcome the Solid Tumor Challenge
P2860
Q33975595-6FB88444-22E5-4451-89BE-33B90990C45BQ37629088-09E9415A-FD88-4CAB-AB69-C6E1490A4313Q38068494-272DCFD1-BD93-46AA-80F4-D1854FC3010AQ38120535-AA2319A3-BF3D-4362-B5F3-4BB03BA66E67Q38150365-5E834EFD-B134-46ED-9B1C-43B0A57B17DAQ40912746-E14E608C-6091-4E08-A064-34FBCD2D89D6Q47103891-1DE8E7D1-1A71-4FA0-A279-5285FDCF6212Q58572502-0907CA11-C631-40E1-B5BE-71543F2AEF7A
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
AdCD40L--crossing the valley of death?
@en
type
label
AdCD40L--crossing the valley of death?
@en
prefLabel
AdCD40L--crossing the valley of death?
@en
P2860
P1476
AdCD40L--crossing the valley of death?
@en
P2093
Angelica S I Loskog
Gustav Ullenhag
P2860
P304
P356
10.3109/08830185.2012.692844
P577
2012-08-01T00:00:00Z